Vesely MD - Search Results

1

The CD8α-PILRα interaction maintains CD8⁺ T cell quiescence.

Zheng L, Han X, Yao S, Zhu Y, Klement J, Wu S, Ji L, Zhu G, Cheng X, Tobiasova Z, Yu W, Huang B, Vesely MD, Wang J, Zhang J, Quinlan E, Chen L. Zheng L, et al. Among authors: vesely md. Science. 2022 May 27;376(6596):996-1001. doi: 10.1126/science.aaz8658. Epub 2022 May 26. Science. 2022. PMID: 35617401

2

Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.

Han X, Vesely MD. Han X, et al. Among authors: vesely md. Int Rev Cell Mol Biol. 2019;342:1-25. doi: 10.1016/bs.ircmb.2018.07.003. Epub 2018 Aug 20. Int Rev Cell Mol Biol. 2019. PMID: 30635089 Free PMC article. Review.

3

PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.

Han X, Vesely MD, Yang W, Sanmamed MF, Badri T, Alawa J, López-Giráldez F, Gaule P, Lee SW, Zhang JP, Nie X, Nassar A, Boto A, Flies DB, Zheng L, Kim TK, Moeckel GW, McNiff JM, Chen L. Han X, et al. Among authors: vesely md. Sci Transl Med. 2019 Dec 11;11(522):eaax1159. doi: 10.1126/scitranslmed.aax1159. Sci Transl Med. 2019. PMID: 31826980

4

Normalization Cancer Immunotherapy for Melanoma.

Vesely MD, Chen L. Vesely MD, et al. J Invest Dermatol. 2020 Jun;140(6):1134-1142. doi: 10.1016/j.jid.2020.02.005. Epub 2020 Feb 22. J Invest Dermatol. 2020. PMID: 32092349 Free PMC article.

5

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.

Yeung J, Yaghoobi V, Aung TN, Vesely MD, Zhang T, Gaule P, Gunel M, Rimm DL, Chen L. Yeung J, et al. Among authors: vesely md. J Neuropathol Exp Neurol. 2021 Jan 20;80(2):150-159. doi: 10.1093/jnen/nlaa152. J Neuropathol Exp Neurol. 2021. PMID: 33393633

6

A Burned-Out CD8⁺ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy.

Sanmamed MF, Nie X, Desai SS, Villaroel-Espindola F, Badri T, Zhao D, Kim AW, Ji L, Zhang T, Quinlan E, Cheng X, Han X, Vesely MD, Nassar AF, Sun J, Zhang Y, Kim TK, Wang J, Melero I, Herbst RS, Schalper KA, Chen L. Sanmamed MF, et al. Among authors: vesely md. Cancer Discov. 2021 Jul;11(7):1700-1715. doi: 10.1158/2159-8290.CD-20-0962. Epub 2021 Mar 3. Cancer Discov. 2021. PMID: 33658301 Free PMC article.

7

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.

Yeung J, Yaghoobi V, Miyagishima D, Vesely MD, Zhang T, Badri T, Nassar A, Han X, Sanmamed MF, Youngblood M, Peyre M, Kalamarides M, Rimm DL, Gunel M, Chen L. Yeung J, et al. Among authors: vesely md. Neuro Oncol. 2021 Nov 2;23(11):1922-1935. doi: 10.1093/neuonc/noab075. Neuro Oncol. 2021. PMID: 33914067 Free PMC article.

8

Resistance Mechanisms to Anti-PD Cancer Immunotherapy.

Vesely MD, Zhang T, Chen L. Vesely MD, et al. Annu Rev Immunol. 2022 Apr 26;40:45-74. doi: 10.1146/annurev-immunol-070621-030155. Annu Rev Immunol. 2022. PMID: 35471840 Review.

9

Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes.

Vesely MD, Kidacki M, Gaule P, Gupta S, Chan NNN, Han X, Yeung JT, Chen L. Vesely MD, et al. J Invest Dermatol. 2024 Jan;144(1):106-115.e4. doi: 10.1016/j.jid.2023.07.008. Epub 2023 Aug 8. J Invest Dermatol. 2024. PMID: 37562584

10

Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.

Little AJ, Vesely MD. Little AJ, et al. Among authors: vesely md. Yale J Biol Med. 2020 Mar 27;93(1):81-95. eCollection 2020 Mar. Yale J Biol Med. 2020. PMID: 32226339 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page